Glass, J., Won, M., Schultz, C. J., Brat, D., Bartlett, N. L., Suh, J. H., . . . Mehta, M. P. (2016). Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. J Clin Oncol.
Chicago-стиль цитированияGlass, Jon, et al. "Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227." J Clin Oncol 2016.
MLA-цитированиеGlass, Jon, et al. "Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227." J Clin Oncol 2016.